Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Renalytix AI (RNLX – Research Report) and Cognyte Software (CGNT – Research Report).
Renalytix AI (RNLX)
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Renalytix AI, with a price target of $15.00. The company’s shares closed last Monday at $2.60, close to its 52-week low of $2.23.
According to TipRanks.com, Chen has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Renalytix AI with a $9.00 average price target.
See the top stocks recommended by analysts >>
Cognyte Software (CGNT)
Needham analyst Mike Cikos downgraded Cognyte Software to Hold today. The company’s shares closed last Monday at $5.07, close to its 52-week low of $3.91.
According to TipRanks.com, Cikos is a 2-star analyst with an average return of
Currently, the analyst consensus on Cognyte Software is a Hold with an average price target of $6.50.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on RNLX:
